NO990012D0 - New erythromycins and methods for their preparation - Google Patents

New erythromycins and methods for their preparation

Info

Publication number
NO990012D0
NO990012D0 NO990012A NO990012A NO990012D0 NO 990012 D0 NO990012 D0 NO 990012D0 NO 990012 A NO990012 A NO 990012A NO 990012 A NO990012 A NO 990012A NO 990012 D0 NO990012 D0 NO 990012D0
Authority
NO
Norway
Prior art keywords
preparation
methods
erythromycins
new
new erythromycins
Prior art date
Application number
NO990012A
Other languages
Norwegian (no)
Other versions
NO990012L (en
Inventor
Peter Francis Leadlay
James Staunton
Jesus Cortes
Michael Stephen Pacey
Original Assignee
Biotica Tech Ltd
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9614189.0A external-priority patent/GB9614189D0/en
Priority claimed from GBGB9710962.3A external-priority patent/GB9710962D0/en
Application filed by Biotica Tech Ltd, Pfizer filed Critical Biotica Tech Ltd
Publication of NO990012D0 publication Critical patent/NO990012D0/en
Publication of NO990012L publication Critical patent/NO990012L/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52Genes encoding for enzymes or proenzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88Lyases (4.)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/44Preparation of O-glycosides, e.g. glucosides
    • C12P19/60Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C12P19/62Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO990012A 1996-07-05 1999-01-04 New erythromycins and methods for their preparation NO990012L (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9614189.0A GB9614189D0 (en) 1996-07-05 1996-07-05 Polyketides and their synthesis
US2418896P 1996-08-19 1996-08-19
GBGB9710962.3A GB9710962D0 (en) 1997-05-28 1997-05-28 Polyketides and their synthesis
PCT/GB1997/001810 WO1998001571A2 (en) 1996-07-05 1997-07-04 Erythromycins and process for their preparation

Publications (2)

Publication Number Publication Date
NO990012D0 true NO990012D0 (en) 1999-01-04
NO990012L NO990012L (en) 1999-02-23

Family

ID=27268361

Family Applications (1)

Application Number Title Priority Date Filing Date
NO990012A NO990012L (en) 1996-07-05 1999-01-04 New erythromycins and methods for their preparation

Country Status (28)

Country Link
EP (3) EP0909327B1 (en)
JP (2) JP2000511063A (en)
KR (1) KR20000023579A (en)
CN (1) CN1179046C (en)
AP (1) AP1029A (en)
AT (2) ATE451455T1 (en)
AU (2) AU731654B2 (en)
BG (1) BG103133A (en)
BR (1) BR9710209A (en)
CA (2) CA2259420C (en)
DE (2) DE69739688D1 (en)
DK (2) DK0910633T3 (en)
EA (1) EA001744B1 (en)
EE (1) EE03976B1 (en)
ES (2) ES2244001T3 (en)
GB (1) GB2331518B (en)
GE (1) GEP20012348B (en)
IL (1) IL127916A0 (en)
IS (1) IS4940A (en)
NO (1) NO990012L (en)
NZ (1) NZ333861A (en)
OA (1) OA10952A (en)
PL (1) PL331285A1 (en)
PT (1) PT909327E (en)
SI (1) SI0910633T1 (en)
SK (1) SK182498A3 (en)
TR (1) TR199900006T2 (en)
WO (2) WO1998001546A2 (en)

Families Citing this family (76)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6060234A (en) * 1991-01-17 2000-05-09 Abbott Laboratories Polyketide derivatives and recombinant methods for making same
US6063561A (en) * 1991-01-17 2000-05-16 Abbott Laboratories Polyketide derivatives and recombinant methods for making same
US6558942B1 (en) 1994-05-06 2003-05-06 The Leland Stanford Junior University Combinatorial polyketide libraries produced using a modular PKS gene cluster as scaffold
US20030170725A1 (en) 1993-09-20 2003-09-11 Chaitan Khosla Combinatorial polyketide libraries produced using a modular PKS gene cluster as scaffold
US6927057B2 (en) 1993-09-20 2005-08-09 Kosan Biosciences Macrolide analogs
US6500960B1 (en) 1995-07-06 2002-12-31 Stanford University (Board Of Trustees Of The Leland Stanford Junior University) Method to produce novel polyketides
US5712146A (en) 1993-09-20 1998-01-27 The Leland Stanford Junior University Recombinant combinatorial genetic library for the production of novel polyketides
US6495348B1 (en) 1993-10-07 2002-12-17 Regents Of The University Of Minnesota Mitomycin biosynthetic gene cluster
EP1493814A1 (en) 1995-07-06 2005-01-05 The Leland Stanford Junior University Cell-free synthesis of polyketides
US6600029B1 (en) 1995-12-19 2003-07-29 Regents Of The University Of Minnesota Metabolic engineering of polyhydroxyalkanoate monomer synthases
US6271255B1 (en) 1996-07-05 2001-08-07 Biotica Technology Limited Erythromycins and process for their preparation
US6399789B1 (en) 1996-12-18 2002-06-04 Kosan Biosciences, Inc. Multi-plasmid method for preparing large libraries of polyketides and non-ribosomal peptides
IL132590A0 (en) 1997-04-30 2001-03-19 Kosan Biosciences Inc Combinatorial polyketide libraries produced using a modular pks gene cluster as scaffold
US6503741B1 (en) 1998-05-28 2003-01-07 Kosan Biosciences, Inc. Polyketide synthase genes from Streptomyces venezuelae
US6902913B2 (en) 1997-04-30 2005-06-07 Kosan Biosciences, Inc. Recombinant narbonolide polyketide synthase
JP2008169226A (en) * 1997-04-30 2008-07-24 Kosan Biosciences Inc Combinatorial polyketide libraries produced using a modular pks gene cluster as scaffold
US6117659A (en) * 1997-04-30 2000-09-12 Kosan Biosciences, Inc. Recombinant narbonolide polyketide synthase
CN1188520C (en) 1997-07-10 2005-02-09 高山生物科学股份有限公司 Production of polyketies in plants
AP1060A (en) 1998-01-02 2002-04-23 Pfizer Prod Inc Novel erythromycin derivatives.
EP1045912A1 (en) * 1998-01-14 2000-10-25 Glaxo Group Limited Polyketides and their synthesis
EP1082439A2 (en) * 1998-05-28 2001-03-14 Kosan Biosciences, Inc. Recombinant narbonolide polyketide synthase
US6265202B1 (en) 1998-06-26 2001-07-24 Regents Of The University Of Minnesota DNA encoding methymycin and pikromycin
GB9814006D0 (en) 1998-06-29 1998-08-26 Biotica Tech Ltd Polyketides and their synthesis
US6221641B1 (en) 1998-07-02 2001-04-24 Leland Stanford Junior University Method for making polyketides
GB9814622D0 (en) * 1998-07-06 1998-09-02 Biotica Tech Ltd Polyketides,their preparation,and materials for use therein
EP1124968A2 (en) 1998-10-28 2001-08-22 Kosan Biosciences, Inc. Library of novel "unnatural" natural products
IL142628A0 (en) 1998-11-03 2002-03-10 Pfizer Prod Inc Novel macrolide antibiotics
US6358712B1 (en) 1999-01-05 2002-03-19 Trustee Of Boston University Ordered gene assembly
EA200100623A1 (en) 1999-01-27 2002-02-28 Пфайзер Продактс Инк. KETOLID ANTIBIOTICS
US6753173B1 (en) 1999-02-09 2004-06-22 Board Of Trustees Of The Leland Stanford Junior University Methods to mediate polyketide synthase module effectiveness
US7001748B2 (en) 1999-02-09 2006-02-21 The Board Of Trustees Of The Leland Stanford Junior University Methods of making polyketides using hybrid polyketide synthases
US6514944B2 (en) 1999-04-16 2003-02-04 Kosan Biosciences, Inc. Macrolide antiinfective agents
US6458771B1 (en) 1999-04-16 2002-10-01 Ortho-Mcneil Pharmaceutical, Inc. Ketolide antibacterials
CN1241931C (en) 1999-04-16 2006-02-15 高山生物科学股份有限公司 Macrolide antinfective agents
US6590083B1 (en) 1999-04-16 2003-07-08 Ortho-Mcneil Pharmaceutical, Inc. Ketolide antibacterials
US6939861B2 (en) 1999-04-16 2005-09-06 Kosan Biosciences, Inc. Amido macrolides
US6451768B1 (en) 1999-04-16 2002-09-17 Kosan Biosciences, Inc. Macrolide antiinfective agents
EA200100983A1 (en) 1999-05-24 2002-10-31 Пфайзер Продактс Инк. DERIVATIVES 13-METHYLERITROMYCIN
GB9912563D0 (en) * 1999-05-28 1999-07-28 Biotica Tech Ltd Polyketides and their synthesis
ES2283344T3 (en) 1999-10-29 2007-11-01 Kosan Biosciences, Inc. RAPAMYCIN ANALOGS.
EP1101769A3 (en) 1999-11-18 2001-10-24 Pfizer Products Inc. Nitrogen containing erythromycin derivatives
EP1255763A2 (en) 2000-02-18 2002-11-13 Kosan Biosciences, Inc. Motilide compounds
EP1146051A3 (en) * 2000-04-10 2001-10-31 Pfizer Products Inc. Erythromycin A derivatives
EP1278881B1 (en) 2000-04-13 2009-12-30 Biotica Technology Limited Hybrid glycosylated products and their production and use
DK1492404T3 (en) * 2002-02-19 2012-04-23 Dow Agrosciences Llc New spin-forming polyketide synthases
EP1967520A2 (en) 2002-07-16 2008-09-10 Biotica Technology Limited Production of polyketides and other natural products
DK200201957A (en) 2002-12-20 2003-01-20 Alpharma Aps 10-substituted erythromycin ketolides and methods of making
GB0230217D0 (en) * 2002-12-27 2003-02-05 Biotica Tech Ltd Borrelidin-producing polyketide synthase and its uses
EP2535042A1 (en) 2003-06-16 2012-12-19 ANDRX Pharmaceuticals LLC. Oral sustained-release composition comprising a macrolide
GB0327720D0 (en) 2003-11-28 2003-12-31 Biotica Tech Ltd Erythromycins and process for their preparation
GB0417852D0 (en) 2004-08-11 2004-09-15 Biotica Tech Ltd Production of polyketides and other natural products
US7582611B2 (en) * 2005-05-24 2009-09-01 Pfizer Inc. Motilide compounds
EP2342335B1 (en) 2008-09-24 2015-09-16 Shanghai Institute Of Organic Chemistry, Chinese Academy Of Sciences Novel gene cluster
GB0904540D0 (en) 2009-03-17 2009-04-29 Biotica Tech Ltd Novel compounds and methods for their production
CN101519637B (en) * 2009-04-07 2011-06-15 华东理工大学 Red Saccharopolyspora and method for producing erythromycin by fermenting Saccharopolyspora
GB0914589D0 (en) 2009-08-20 2009-09-30 Biotica Tech Ltd Novel compounds and methods for their production
WO2011098805A1 (en) 2010-02-09 2011-08-18 Biotica Technology Limited Sanglifehrin based compounds
WO2011098808A1 (en) 2010-02-09 2011-08-18 Biotica Technology Limited Sanglifehrin based compounds
ES2541853T3 (en) 2010-02-09 2015-07-27 Neurovive Pharmaceutical Ab Sangliferin based compounds
GB201118334D0 (en) 2011-10-24 2011-12-07 Biotica Tech Ltd Novel dosage form
WO2013172782A1 (en) * 2012-05-16 2013-11-21 Nanyang Technological University A polyketide synthase construct and its use in the preparation of polyketides
EP4289950A3 (en) 2015-01-09 2024-01-24 Revolution Medicines, Inc. Macrocyclic compounds that participate in cooperative binding and medical uses thereof
KR102615448B1 (en) 2016-04-12 2023-12-19 징코 바이오웍스, 인크. Compositions and methods for the production of compounds
SI3491132T1 (en) 2016-07-29 2021-11-30 Isomerase Therapeutics Limited Methods and constructs for producing hybrid polyketides (pks) of a type 1 modular pks or hybrid modular non ribosomal peptides (nrps)
AU2017350898A1 (en) * 2016-10-28 2019-06-13 Ginkgo Bioworks, Inc. Compositions and methods for the production of compounds
KR20190099396A (en) 2016-10-28 2019-08-27 징코 바이오웍스, 인크. Compositions and Methods for the Production of Compounds
EP3585795B1 (en) 2017-02-22 2021-06-09 ISR Immune System Regulation Holding AB (publ) Novel immune stimulating macrolides
CN110741011A (en) 2017-02-22 2020-01-31 免疫系统调节控股有限公司 Novel immunostimulatory macrolides
WO2019180265A1 (en) 2018-03-23 2019-09-26 Immune System Regulation Holding Ab Combinations of macrolide compounds and immune checkpoint inhibitors
GB2586113B (en) 2019-01-22 2022-02-09 Aeovian Pharmaceuticals Inc MTORC modulators and uses thereof
CN114867735A (en) 2019-11-04 2022-08-05 锐新医药公司 RAS inhibitors
US11566007B2 (en) 2019-11-04 2023-01-31 Revolution Medicines, Inc. Ras inhibitors
BR112022008534A2 (en) 2019-11-04 2022-08-09 Revolution Medicines Inc COMPOUNDS, PHARMACEUTICAL COMPOSITION, CONJUGATE AND METHODS TO TREAT CANCER AND TO TREAT A RAS PROTEIN-RELATED DISORDER
KR20230067635A (en) 2020-09-15 2023-05-16 레볼루션 메디슨즈, 인크. Indole derivatives as RAS inhibitors in the treatment of cancer
KR20240014756A (en) 2022-07-26 2024-02-02 강원대학교산학협력단 Ery-loaded chitosan-bound chicken bone-derived hydroxyapatite nanoparticles and method for preparing the same
CN117288869B (en) * 2023-11-24 2024-02-09 中国医学科学院医药生物技术研究所 Method for detecting p-toluenesulfonate impurities in bulk drug

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993013663A1 (en) * 1992-01-17 1993-07-22 Abbott Laboratories Method of directing biosynthesis of specific polyketides
US6060234A (en) * 1991-01-17 2000-05-09 Abbott Laboratories Polyketide derivatives and recombinant methods for making same
US5712146A (en) * 1993-09-20 1998-01-27 The Leland Stanford Junior University Recombinant combinatorial genetic library for the production of novel polyketides
ATE297992T1 (en) * 1993-09-20 2005-07-15 Univ Leland Stanford Junior RECOMBINANT PRODUCTION OF AROMATIC POLYKETIDES

Also Published As

Publication number Publication date
DK0909327T3 (en) 2005-09-26
TR199900006T2 (en) 1999-04-21
AU3450997A (en) 1998-02-02
CN1179046C (en) 2004-12-08
GB2331518A (en) 1999-05-26
OA10952A (en) 2002-02-25
ATE296893T1 (en) 2005-06-15
EP2182067A2 (en) 2010-05-05
DE69733416D1 (en) 2005-07-07
WO1998001546A2 (en) 1998-01-15
WO1998001571A3 (en) 1998-02-19
CA2259420A1 (en) 1998-01-15
JP2000516450A (en) 2000-12-12
DE69739688D1 (en) 2010-01-21
AU731654B2 (en) 2001-04-05
NO990012L (en) 1999-02-23
EP2182067A3 (en) 2010-07-14
KR20000023579A (en) 2000-04-25
CN1229438A (en) 1999-09-22
GB2331518B (en) 2001-03-14
EP0909327A2 (en) 1999-04-21
CA2259463A1 (en) 1998-01-15
PT909327E (en) 2005-10-31
PL331285A1 (en) 1999-07-05
ATE451455T1 (en) 2009-12-15
ES2337424T3 (en) 2010-04-23
JP2000511063A (en) 2000-08-29
IS4940A (en) 1999-01-04
EP0910633A2 (en) 1999-04-28
EP0910633B1 (en) 2009-12-09
CA2259420C (en) 2007-09-18
GB9900156D0 (en) 1999-02-24
DK0910633T3 (en) 2010-03-29
WO1998001571A2 (en) 1998-01-15
IL127916A0 (en) 1999-11-30
EA001744B1 (en) 2001-08-27
AU3451497A (en) 1998-02-02
ES2244001T3 (en) 2005-12-01
SK182498A3 (en) 2000-05-16
GEP20012348B (en) 2001-01-25
BR9710209A (en) 2000-01-11
AP1029A (en) 2001-12-11
JP4173551B2 (en) 2008-10-29
EE03976B1 (en) 2003-02-17
SI0910633T1 (en) 2010-04-30
AP9901444A0 (en) 1999-03-31
WO1998001546A3 (en) 1998-04-09
DE69733416T2 (en) 2006-04-27
EP0909327B1 (en) 2005-06-01
NZ333861A (en) 2000-08-25
BG103133A (en) 2000-04-28
EE9900014A (en) 1999-08-16
EA199900087A1 (en) 1999-08-26
AU731301B2 (en) 2001-03-29

Similar Documents

Publication Publication Date Title
NO990012D0 (en) New erythromycins and methods for their preparation
NO992297D0 (en) Procedure and new connections
NO975711L (en) New dolastatin derivatives, their preparation and use
NO984695L (en) New isoflavone-enriched soy protein products and their preparation
NO944187L (en) Isoquinolines, Methods for their Preparation and Use
NO20000627D0 (en) Pre-coated controlled - release - fertilizers and methods for their preparation
NO983965D0 (en) Polymer-organolay composites and their preparation
DK0811006T3 (en) Benzopyran-containing compounds and methods for their use
NO976072L (en) Propiophenone derivatives and process for their preparation
DK0869126T3 (en) Dithioland derivatives, their preparation and their therapeutic effect
DK0836615T3 (en) New thrombin inhibitors, their preparation and use
NO20003067L (en) Antipicornavirus compounds and methods for their use and preparation
NO991761D0 (en) New piperidine cotocarboxylic acid derivatives, their preparation and use
NO20005266D0 (en) Novel substituted amides, their preparation and use
NO952677D0 (en) New dihydropyrrolopyridinone and oxazolopyridinone compounds, their preparation and pharmaceutical preparations
NO984717D0 (en) New hydroxamic acid derivatives, their preparation and use
NO995909L (en) Crystalline macrolides and process for their preparation
NO914288D0 (en) NEW 2-SUCCARINYLMETHYLARCARBOXYLATES AND PROCEDURES FOR THEIR PREPARATION
NO941517L (en) 2-amino-4-quinoline dihydropyridines, processes for their preparation and their use
NO954763D0 (en) Piperidine derivatives, their preparation and use
NO984624D0 (en) New furan-diarylmethylidene derivatives, methods of their preparation and therapeutic uses thereof
NO973230D0 (en) New peptides, their preparation and use
NO984921D0 (en) Tienopyridine derivatives and their use
NO955242D0 (en) Piperidine derivatives, processes for their preparation and their therapeutic use
NO972821D0 (en) 1-C-perfluoroalkyl glycosides, their preparation and use

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application